
Tom Powles
@tompowles1
Interested in Urology Cancers, biomarkers and drug development.
ID: 1206580727296544769
16-12-2019 14:24:22
1,1K Tweet
12,12K Followers
62 Following

TROPICS4 sacituzimab govitecan vs chemo in pretreated UC Annals of Oncology OS & PFS HRs=0.86. RR 23 vs 14, but G3+ TRAE 67 vs 35% with ⬆️ G5 TRD. While there is activity the ⬆️ tox & lower RR compared to EV/erda was problematic. Phase 2 Data on 2 other TROP2/TOPO1 ADCs #ASCOGU25
